[S35] The Path for Bacteriophage as the Pharmaceutical Products in Japan

5:50 PM - 6:10 PM JST(8:50 AM - 9:10 AM UTC)

[S35-4] A role of live bio therapeutic products including phage therapy as novel therapeutic options in infectious disease by antimicrobial resistant bacteria.

○Atsushi Shiota^1,2,3 (1. Keio Univ School of Med, 2. Keio Univ WPI-Bio2Q, 3. Microbiopharm Japan Co. Ltd.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.